Design and synthesis of some -carboline derivatives as multi-target anticancer agents

被引：31
作者：
Abdelsalam, Mohamed A. [1 ]
AboulWafa, Omaima M. [1 ]
Badawey, El-Sayed A. M. [1 ]
El-Shoukrofy, Mai S. [1 ]
El-Miligy, Mostafa M. [1 ]
Gouda, Noha [2 ]
机构：
[1] Univ Alexandria, Dept Pharmaceut Chem, Fac Pharm, Alexandria 21521, Egypt
[2] Univ Alexandria, Dept Pharmaceut, Fac Pharm, Alexandria 21521, Egypt
来源：
FUTURE MEDICINAL CHEMISTRY | 2018年 / 10卷 / 24期
关键词：
anticancer activity; apoptosis; -carboline; cell cycle arrest; docking; KSP; multitarget agents; National Cancer Institute; topoisomerase-I; triazoles; BIOLOGICAL EVALUATION; TOPOISOMERASE-II; DRUG DISCOVERY; DNA; ANTITUMOR; CANCER; INHIBITORS; CHROMATOGRAPHY; LIPOPHILICITY; CAMPTOTHECIN;
D O I：
10.4155/fmc-2018-0226
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Aim: Some anticancer -carbolines exhibited dual inhibition of topo-I and KSP. Methodology/Results: Novel -carbolines were synthesized and screened for their anticancer activity according to the NCI protocol. Five dose assays results indicated that compounds 9, 10, 12, 17 and 20 were potent and non selective anticancer agents; the sulfanyltriazole 12 was the most potent. Compounds 10, 12 and 20 showed dual topo-I and KSP inhibition with compound 12 being the most potent. Active compounds elicited Pre-G1 apoptosis and cell cycle arrest at G2/M phase of melanoma MDA-MB-435 cells. Docking results, in silico physicochemical and absorption, distribution, metabolism, excretion (ADME) properties were appropriate. Conclusion: Compounds 10, 12 and 20 are potent apoptosis-inducing multitarget anticancer agents that act via dual inhibition of topo-I and KSP-ATPase.
引用
收藏
页码：2791 / 2814
页数：24
相关论文
共 52 条
[1]   Design, synthesis, anticancer screening, docking studies and in silico ADME prediction of some β-carboline derivatives [J].
Abdelsalam, Mohamed A. ;
AboulWafa, Omaima M. ;
Badawey, El-Sayed A. M. ;
El-Shoukrofy, Mai S. ;
El-Miligy, Mostafa M. ;
Gouda, Noha ;
Elaasser, Mahmoud M. .
FUTURE MEDICINAL CHEMISTRY, 2018, 10 (10) :1159-1175
[2]  
[Anonymous], 2004, TEST 117 PART COEFF
[3]   Synthesis and evaluation of novel hybrids β-carboline-4-thiazolidinones as potential antitumor and antiviral agents [J].
Barbosa, Valeria Aquilino ;
Barea, Paula ;
Mazia, Renata Sespede ;
Ueda-Nakamura, Tania ;
da Costa, Willian Ferreira ;
Foglio, Mary Ann ;
Goes Ruiz, Ana Lucia T. ;
de Carvalho, Joao Ernesto ;
Vendramini-Costa, Debora Barbosa ;
Nakamura, Celso Vataru ;
Sarragiotto, Maria Helena .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 124 :1093-1104
[4]   The discovery of tetrahydro-β-carbolines as inhibitors of the kinesin Eg5 [J].
Barsanti, Paul A. ;
Wang, Weibo ;
Ni, Zhi-Jie ;
Duhl, David ;
Brammeier, Nathan ;
Martin, Eric ;
Bussiere, Dirksen ;
Walter, Annette O. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2010, 20 (01) :157-160
[5]   Mitotic kinesins: Prospects for antimitotic drug discovery [J].
Bergnes, G ;
Brejc, K ;
Belmont, L .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (02) :127-145
[6]   SOME PRACTICAL CONSIDERATIONS AND APPLICATIONS OF THE NATIONAL-CANCER-INSTITUTE IN-VITRO ANTICANCER DRUG DISCOVERY SCREEN [J].
BOYD, MR ;
PAULI, KD .
DRUG DEVELOPMENT RESEARCH, 1995, 34 (02) :91-109
[7]   Synthesis of novel β-carboline based chalcones with high cytotoxic activity against breast cancer cells [J].
Chauhan, Shikha S. ;
Singh, Anup K. ;
Meena, Sanjeev ;
Lohani, Minaxi ;
Singh, Akhilesh ;
Arya, Rakesh K. ;
Cheruvu, Srikanth H. ;
Sarkar, Jayanta ;
Gayen, Jiaur R. ;
Datta, Dipak ;
Chauhan, Prem M. S. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (13) :2820-2824
[8]   Computational methods for the prediction of 'drug-likeness' [J].
Clark, DE ;
Pickett, SD .
DRUG DISCOVERY TODAY, 2000, 5 (02) :49-58
[9]   Synthesis and in vitro antitumor activity of new quinoxaline derivatives [J].
Corona, Paola ;
Carta, Antonio ;
Loriga, Mario ;
Vitale, Gabriella ;
Paglietti, Giuseppe .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (04) :1579-1591
[10]  
DeBonis S, 2004, MOL CANCER THER, V3, P1079
123456